Skip to main content

News

18
Aug

1,000 cancer patients treated: promising results of particle therapy

Just over 1,000 cancer patients, including many children and adolescents, have completed particle therapy at MedAustron since the start of operations at the end of 2016. A lower risk of side and long-term effects, better tumor control in complex indications, and improved quality of life are the promises of this form of therapy. A first review is optimistic about all these factors. The goal of ion therapy is not only to successfully treat the tumor, but also to limit side effects and restore or maintain quality of life. This form of radiation therapy uses charged particles to deli...

Read more

10
Aug

Online Seminar: Immunogenic Potential

Join our radiation oncology online seminar: The State-of-the-Art In Immunogenic Potential of Photon and Particle Radiotherapy September 23, 2021 • 03.00 –08.00 p.m. CET Online-Seminar via MS Teams View the program To register, please use the form on the event page or send an email to events@medaustron.at. The participation link will be sent separately.

Read more

21
Dec

Cancer therapy with carbon ions: Already 100 patients treated

In only six countries worldwide, irradiation with carbon ions is available to cancer patient*. MedAustron has been offering this form of therapy since July 2019 and today started the 100th patient treatment. Experience gained so far was recently presented to a broad professional audience for the first time in an online seminar.  In radiation therapy with charged particles, carbon ions are used in addition to the more widespread protons. Both particles have the advantage that the radiation exposure in healthy tissue can be kept low, thus reducing the risk of side effects and late ...

Read more

23
Jul

New technical milestone on the way to full operation

The MedAustron team recently succeeded in bringing the particle beam into the third patient treatment room for the first time. This important milestone brings the cancer treatment and research center one step closer to full operation. The first treatments in this third and final room are expected to begin in 2022. At MedAustron, the radiation of cancer patients is currently carried out in two rooms. Since the centre has been put into operation, more than 700 people have already completed their treatment there. The third room will not only ensure that even more patients benefit fr...

Read more

11
Mar

Current Information concerning coronavirus (COVID-19)

In relation to the recent developments concerning the spread of COVID-19 (coronavirus), we would like announce that the MedAustron Ion Therapy Center will remain open for patients. We are taking all necessary precautions to reduce the risk of infection for our patients and employees and are strictly following the recommendations issued by the authorities. If patients are not able to come to their treatment sessions on their own, we kindly ask that only one accompanying person joins them. At the same time, we urge all patients and accompanying persons to abide by the official prot...

Read more

06
Dec

Meeting of the Advisory Board MedAustron Research

Yesterday the Advisory Board MedAustron Research met at the nearby Technology and Research Centre TFZ. DI Dr. Thomas Schreiner, coordinator of our non-clinical research (left), as well as four colleagues from TU and MedUni Vienna are members of the Advisory Board MedAustron Research, which is responsible for the non-clinical part of MedAustron. The Board was established by and reports to the Federal Ministry of Education, Science and Research. The Advisory Board determines the basic strategic direction of research with federal resources and regularly evaluates from a scientific p...

Read more

16
Oct

MedAustron @ PTCOG-NA

The annual conference of the Particle Therapy Cooperative Group - North America (PTCOG-NA) brings together radiation oncologists, medical physicists, dosimetrists and radiation therapists to advance their expertise on the latest clinical applications, outcomes and physics and biology experiences with particle therapy. MedAustron was strongly represented at this year's edition of the meeting in Miami, Florida with several lectures, poster presentations and an information booth on carbon ion therapy. Header l.t.r.: Prof. Dr. Eugen B. Hug (Medical Director MedAustron & President...

Read more

23
Jul

New era for cancer treatment by irradiation with carbon ions

Particle therapy for cancer treatment has been successfully used at MedAustron for two and a half years. Whereas patients were previously treated exclusively with protons, carbon ion therapy is now also available. This form of treatment opens up new opportunities for tumors that were previously difficult or impossible to treat. MedAustron is thus finally joining the ranks of only six centers worldwide that can combat tumors with both protons and carbon ions.   Particle or ion therapy as a form of radiation therapy makes it possible to reduce radiation exposure in the healthy tis...

Read more

07
Oct

»World Forum on Particle Therapy«: international experts define strategies for the future of particle therapy

On the initiative of the MedAustron Ion Therapy Center (AUT) and in collaboration with the MD Anderson Cancer Center (USA), the world leaders in particle therapy met last week at Grafenegg castle in Austria at the "World Forum on Particle Therapy". For the first time, they discussed the visions and challenges for this form of therapy within such a framework in order to forge joint strategies for the coming years.    Cancer indications for particle therapy are expanding, the technology is developing rapidly – but the number of centers for particle therapy worldwide is still modes...

Read more